NP90726m Vedolizumab (Entyvio®)
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS PUBLIC SERVICES DELIVERY SCOTLAND) (PSD SCOTLAND)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £48M
- Sector
- HEALTH
- Published
- 25 Jun 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
1 supplier
- Takeda London
Description
Supply of Vedolizumab (Entyvio®) to NHS Scotland.
Total Quantity or Scope
The Framework Agreement is for the supply of Vedolizumab (Entyvio®) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participants.
Award Detail
| 1 | Takeda (London)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twelve (12) month Framework Agreement duration and the thirty six (36) month optional extension period of the Framework Agreement NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=835484. (SC Ref:835484)
Reference
- FTS 059697-2026